test has a sensibility and specificity higher than
99% with a very low incidence of false positives, below
0,1% of cases. PrenatalSAFE® KARYO PLUS
highlights the 99,1% of fetal chromosomal aneuploidies observed at the delivery, reaching a detection rate level very similar to the one of traditional fetal karyotype (96,9) and molecular fetal karyotype obtained through invasive prenatal diagnosis techniques.